We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
After a lengthy review, the U.S. Pharmacopeia (USP) has decided to continue recommending the use of decades-old reagents derived from horseshoe crab blood for detecting endotoxins in drugs rather than press for the use of new synthetic substitutes. Read More
The European Commission is asking for comments on a new, wide-ranging strategy aimed at ensuring patients have access to safe, affordable and high-quality drugs across Europe. Read More
A Texas study of convalescent plasma as a treatment for critically ill COVID-19 patients found the blood-based treatment to be safe for severely infected patients. Read More
AstraZeneca and Accent Therapeutics have teamed up to develop cancer therapies using RNA-modifying proteins in a deal potentially worth more than $1 billion for the small Massachusetts-based startup. Read More
The Lancet and the New England Journal of Medicine (NEJM) yesterday retracted separate studies of two different COVID-19 treatments because of concerns over the underlying data provided by the same data analytics company, Surgisphere. Read More